Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082238 | SCV000114187 | benign | not specified | 2013-08-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000082238 | SCV000247281 | likely benign | not specified | 2015-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000284917 | SCV000636620 | benign | Kleefstra syndrome 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705782 | SCV001840534 | benign | not provided | 2018-08-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705782 | SCV002498084 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | EHMT1: BP4, BP7, BS1 |
Ambry Genetics | RCV002326799 | SCV002627867 | likely benign | Inborn genetic diseases | 2017-11-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003925077 | SCV004740853 | benign | EHMT1-related disorder | 2019-12-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |